284 related articles for article (PubMed ID: 27997977)
21. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
[TBL] [Abstract][Full Text] [Related]
22. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
[TBL] [Abstract][Full Text] [Related]
23. The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice.
Hirako S; Wakayama Y; Kim H; Iizuka Y; Matsumoto A; Wada N; Kimura A; Okabe M; Sakagami J; Suzuki M; Takenoya F; Shioda S
Obes Res Clin Pract; 2016; 10(6):710-718. PubMed ID: 26747210
[TBL] [Abstract][Full Text] [Related]
24. Ethanol Extract of
Le TNH; Choi HJ; Jun HS
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684339
[TBL] [Abstract][Full Text] [Related]
25. Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.
Ham JR; Lee HI; Choi RY; Sim MO; Seo KI; Lee MK
Food Funct; 2016 Feb; 7(2):689-97. PubMed ID: 26838182
[TBL] [Abstract][Full Text] [Related]
26. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
27. Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
Gavito AL; Bautista D; Suarez J; Badran S; Arco R; Pavón FJ; Serrano A; Rivera P; Decara J; Cuesta AL; Rodríguez-de-Fonseca F; Baixeras E
PLoS One; 2016; 11(6):e0157956. PubMed ID: 27333268
[TBL] [Abstract][Full Text] [Related]
28. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
29. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
[TBL] [Abstract][Full Text] [Related]
30. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
32. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
33. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
34. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
35. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
Li D; Ikaga R; Yamazaki T
Br J Nutr; 2018 Jun; 119(11):1220-1232. PubMed ID: 29770757
[TBL] [Abstract][Full Text] [Related]
36. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
[TBL] [Abstract][Full Text] [Related]
37. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
38. 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.
Zhang J; Zhang LN; Chen DM; Fu YY; Zhang F; Yang LL; Xia CM; Jiang HW; Tang CL; Xie ZF; Yang F; Li J; Tang J; Li JY
Acta Pharmacol Sin; 2015 Apr; 36(4):483-96. PubMed ID: 25832429
[TBL] [Abstract][Full Text] [Related]
39. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
[TBL] [Abstract][Full Text] [Related]
40. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
